Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials ...

"The future of drug development lies in precision-driven innovation ... We are particularly excited to launch our first ...

Novartis is thriving with double-digit growth, driven by key drugs in oncology, cardiology, immunology, and neurology. See ...

A growing momentum for earlier treatment of psoriasis has the potential to improve outcomes with oral therapies and biologics ...

A Canberra man who pleaded guilty to trafficking drugs denies he had anything to do with the importation of a parcel containing methamphetamines, mailed from California to an address in the ACT.

The Inflation Reduction Act was intended to lower prescription drug costs, but an unintended consequence is threatening the ...

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.

In a small Phase II trial, people with cocaine use disorder who took mavoglurant used the drug less often over a three month ...

New center will use cutting-edge AI to accelerate the creation of life-saving medicines AI Small Molecule Drug Discovery ...

One of the most promising aspects of AI and its integration into the pharmaceutical industry is the technology’s potential to ...

New York City-based The Icahn School of Medicine at Mount Sinai has established a new research center focused on using AI to ...